[EN] S1P RECEPTORS MODULATORS AND THEIR USE THEREOF<br/>[FR] MODULATEURS DES RÉCEPTEURS S1P ET LEUR UTILISATION
申请人:AKAAL PHARMA PTY LTD
公开号:WO2010043000A1
公开(公告)日:2010-04-22
The invention relates to novel compounds that have S1P receptor modulating activity. Further, the invention relates to a pharmaceutical comprising at least one compound of the invention for the treatment of diseases and/or conditions caused by or associated with inappropriate S1P receptor modulating activity or expression, for example, autoimmune response. A further aspect of the invention relates to the use of a pharmaceutical comprising at least one compound of the invention for the manufacture of a medicament for the treatment of diseases and/or conditions caused by or associated with inappropriate S1P receptor modulating activity or expression such as autoimmune response.
Phosphinhaltige terpenderivate als optisch aktive liganden in der homogenen katalyse
作者:Wolfgang Beck、Hartmut Menzel
DOI:10.1016/s0022-328x(00)89130-5
日期:1977.6
The optically active bidentate phosphines IIII, derived from (+)-camphoric acid, ()-nopinylamine and ()-pinane-3-carboxylic acid have been obtained. The rhodium(I) complex of I with [Rh(cyclooctene)2Cl]2 catalyses the asymmetrichydrogenation of atropic and of α-acetamidocinnamic acid (4 and 7% optical purity, respectively).